| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.11.19 | Idorsia Pharmaceuticals Ltd: Encouraging Phase 2 data on cenerimod - Idorsia's S1P1 receptor modulator currently investigated for SLE - presented at ACR 2019 | 533 | GlobeNewswire (Deutschland) | A Phase 2 safety study showed that cenerimod reduced circulating lymphocytes in a dose-dependent manner and was safe and well tolerated at doses up to 4 mg in patients with systemic lupus erythematosus... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 4.140 |
| NEL | 1.970 |
| NVIDIA | 1.711 |
| DEUTSCHE BANK | 1.595 |
| BAYER | 1.368 |
| BASF | 1.267 |
| MICROSOFT | 1.260 |
| ALPHABET | 1.248 |
| TUI | 1.204 |
| THYSSENKRUPP | 1.191 |
| TESLA | 1.165 |
| SUPER MICRO COMPUTER | 1.092 |
| BYD | 1.074 |
| RHEINMETALL | 1.041 |
| DELIVERY HERO | 1.031 |
| INTEL | 859 |
| AIXTRON SE | 842 |
| META PLATFORMS | 805 |
| COMMERZBANK | 800 |
| AMAZON | 754 |
| AMS-OSRAM | 707 |
| VARTA | 654 |
| SIEMENS ENERGY | 579 |
| RENK GROUP | 574 |
| PLUG POWER | 560 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
